Correlation Between Oxford BioDynamics and Seres Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oxford BioDynamics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford BioDynamics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford BioDynamics Plc and Seres Therapeutics, you can compare the effects of market volatilities on Oxford BioDynamics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford BioDynamics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford BioDynamics and Seres Therapeutics.

Diversification Opportunities for Oxford BioDynamics and Seres Therapeutics

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Oxford and Seres is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Oxford BioDynamics Plc and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Oxford BioDynamics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford BioDynamics Plc are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Oxford BioDynamics i.e., Oxford BioDynamics and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Oxford BioDynamics and Seres Therapeutics

Assuming the 90 days horizon Oxford BioDynamics Plc is expected to generate 8.24 times more return on investment than Seres Therapeutics. However, Oxford BioDynamics is 8.24 times more volatile than Seres Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  50.00  in Oxford BioDynamics Plc on September 14, 2024 and sell it today you would lose (49.00) from holding Oxford BioDynamics Plc or give up 98.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.63%
ValuesDaily Returns

Oxford BioDynamics Plc  vs.  Seres Therapeutics

 Performance 
       Timeline  
Oxford BioDynamics Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford BioDynamics Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Seres Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Seres Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Seres Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Oxford BioDynamics and Seres Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oxford BioDynamics and Seres Therapeutics

The main advantage of trading using opposite Oxford BioDynamics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford BioDynamics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.
The idea behind Oxford BioDynamics Plc and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities